TRAW 8-K: SEC filing

Traws Pharma

Filed with the SEC on Nov 12, 2026 · accession 0001104659-26-125797

TRAW filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +13.9% by the first close after the filing.

Summary of the filing

Traws Pharma announced Phase 2a results for Ratutrelvir, an inhibitor of the SARS-CoV-2 main protease for COVID-19, and reported completion of a bridging study of Tivoxavir Marboxil.

For details, click here →How to read a 8-K →

Key details

RegistrantTraws Pharma, Inc.

Chief financial officerCharles Parker

How TRAW stock reacted

Close before

$0.25

Nov 11, 2026

First close after

+13.92%

$0.28

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for TRAW, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TRAW?

Click here

Frequently asked questions

What did TRAW file with the SEC on Nov 12, 2026?

TRAW filed a 8-K (SEC filing). Traws Pharma announced Phase 2a results for Ratutrelvir, an inhibitor of the SARS-CoV-2 main protease for COVID-19, and reported completion of a bridging study of Tivoxavir Marboxil.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did TRAW stock react to this filing?

TRAW closed at $0.25 before the filing and $0.28 on Nov 12, 2026 (+13.92%).

Other TRAW SEC filings

Get alerts when TRAW files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TRAW overview TRAW analysis TRAW news Latest SEC filings